Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Hepatocellular × aflibercept × Clear all

Sponsor

Conditions

Neoplasm Metastasis 9 Colorectal Neoplasms 7 Rectal Neoplasms 5 Colorectal Cancer Metastatic 5 Ovarian Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Colonic Neoplasms 3 Uveal Melanoma 2 Melanoma 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Stomach Neoplasms 1 Somatostatinoma 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neurofibromatosis 2 1 Myeloproliferative Disorders 1 Multiple Endocrine Neoplasia Type 1 1 Macular Degeneration 1 Lung Diseases 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Fibrolamellar hepatocellular carcinoma 1

Interventions

Sorafenib 49 pembrolizumab 20 Nivolumab 18 Bevacizumab 16 Radiosurgery 15 Doxorubicin 12 lenvatinib 8 Erlotinib Hydrochloride 7 atezolizumab 6 Ramucirumab 6 Magnetic Resonance Spectroscopy 6 Cisplatin 6 tremelimumab 5 durvalumab 5 cabozantinib 5 Radiofrequency Ablation 5 tislelizumab 4 Sunitinib 4 Ipilimumab 4 regorafenib 3 nintedanib 3 carotuximab 3 bavituximab 3 Ribavirin 3 Radiotherapy 3 Oxaliplatin 3 Mitomycin 3 Leucovorin 3 Fluorouracil 3 Everolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡